Thirdly, the use of EndoCAb IgA but not IgG might be confounded by alcohol‐related aetiology of liver disease [64], which were underrepresented in compensated patient groups, and also be confounded by a defective clearance of IgA and IgA immune complexes in cirrhosis [65]. This evidence concerns the gene CD79A and liver disorder.